Lifecore Biomedical, Inc. De (LFCR) Return on Capital Employed (2011 - 2025)

Lifecore Biomedical's Return on Capital Employed history runs 15 years deep, the most recent figure standing at 8.28% for Q2 2025.

• In Q2 2025, Return on Capital Employed fell 409.0% year-over-year to 8.28%; the TTM figure through May 2025 stood at 8.28% (down 409.0% YoY), while the FY2025 annual figure was 7.97%, down 385.0% from the prior year.
• Return on Capital Employed was 8.28% for Q2 2025 at Lifecore Biomedical, up from 9.48% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 2.28% in Q4 2021 to a low of 27.5% in Q4 2022.
• Historically, Return on Capital Employed has averaged 8.46% across 5 years, with a median of 8.17% in 2025.
• The sharpest annual moves came in 2022 and 2023: Return on Capital Employed plunged 2522 bps in 2022, then surged 1617 bps in 2023.
• A 5-year view of Return on Capital Employed shows it stood at 2.28% in 2021, then plunged by 1104 bps to 27.5% in 2022, then soared by 59 bps to 11.32% in 2023, then surged by 50 bps to 5.69% in 2024, then slumped by 45 bps to 8.28% in 2025.
• The last three Return on Capital Employed figures came in at 8.28% (Q2 2025), 9.48% (Q1 2025), and 5.69% (Q4 2024), per Business Quant data.